All Orchard Supply Stores To Close
A spokesperson for Orchard Supply told ABC7 News that more information is on the way after a report saying all locations will close before the end of the year.
All Posts in "News Team"
Low Carb Diets Have Been Linked to an Early Death
Low-carbohydrate diets like Keto may be great for losing weight, but they may not be so good for your lifespan, according to a new study published in The Lancet.
Researchers followed 15,400 Americans over a span of 25 years to determine the long-term effects of eating (or not eating) carbohydrates — and found that moderate carb eaters lived up to four years longer than low carb eaters.
Greece ends nearly 10 years of bailouts — this is what it means
Monday is an historic day for Greece as nearly a decade of external financial help comes to an end.
The Syriza-led government has managed to end a third bailout rescue, implementing all the measures demanded by creditors, despite earlier doubts whether the inexperienced party would manage to complete the arduous task.
What stocks should you buy with the market at a record high?
The dilemma of what stocks to buy is particularly tricky right now.
If you want to own shares of companies, you’ll be getting into a market that began rising more than nine years ago and now sits near an all-time high. The bull market, now 3,453 days old, will be the longest in history by the end of trading on Wednesday. And the Standard & Poor’s 500, the broadest measure of U.S. stocks, hit a record Tuesday for the first time in six months.
Soybean and pea farmers scramble as China and European trade missions cancel visits
Delegations from China, India, Italy and Spain that were supposed to meet with North Dakota’s bean, pea and lentil growers in September have canceled their visits because of trade tensions.
Researchers use gut bacteria to turn type A or B blood into universal donors
Bacteria found in the human gut could save countless lives by transforming type A or type B blood into type O.
At a meeting of the American Chemical Society today, Steve Withers of the University of British Colombia presented new research suggesting enzymes found in gut bacteria could effectively strip antigens from the two most common blood types. If successful, the discovery would essentially make most types of blood accessible to those who need it, regardless of their blood type.
3 Stocks That Cut You a Check Each Month
Income investors like dividend stocks because owning dividend payers lets them collect predictable streams of cash year after year. By focusing on dividend stocks that grow their payouts over time, investors can even seek to build a portfolio that will produce income that rises along with costs of living.
3 Stocks to Add to Your Social Security Income
As designed, Social Security expects to replace around 40% of a typical retiree’s income, even less than that for those that happen to earn a higher-than-average income. As if that weren’t enough, Social Security’s trust funds are on track to empty by 2034, which would slash average benefits by almost 25% if nothing is done to head off the collapse. If living on somewhere between 30% and 40% of your current income in retirement doesn’t sound all that appealing to you, you need to invest to make up the gap.
Hedge funds are struggling due to Facebook’s plunge, bets against stocks, Goldman says
The so-called “smart money” hedge funds are dramatically underperforming this year.
Goldman Sachs explained the weakness is the result of big positions in Facebook shares and disastrous bets against stocks.
Protected: Certified Organic is Now the Rarest Distinction Among Cannabis Stocks, with Highest Profit Potential
Weekly Market Review – December 21, 2024
Medtronic appoints new chief medical officer for digital surgery and robotics
Neurocrine’s bid to save schizophrenia prospect fails
FDA greenlights over-the-counter hearing aid features for Apple’s AirPods
Oncternal folds all clinical trials after lackluster data drop, patient death
Zenas, MBX and Bicara all head to Nasdaq in hot day for biotech IPOs
FDA pushed to be more open, collaborative to accelerate rare disease R&D
In wake of Q2 revenue drop, Charles River cuts 3% of workforce
Inflammatix collects $57M as it awaits FDA review of infectious disease test
Sanofi’s $80M bet on Fulcrum’s dystrophy drug ends in phase 3 failure after 4 months